Profil bibliographique

Hans Lee

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

2Publications signalées
3Citations signalées
1Affiliations récentes

Les institutions déclarées

The University of Texas MD Anderson Cancer Center

Les domaines associés

Multiple Myeloma Research and TreatmentsAcute Myeloid Leukemia ResearchAmyloidosis: Diagnosis, Treatment, OutcomesIgG4-Related and Inflammatory DiseasesMyeloproliferative Neoplasms: Diagnosis and Treatment

Les publications récentes

Accès ouvert 2026 article OpenAlex

Daratumumab-bortezomib-cyclophosphamide-dexamethasone for newly diagnosed amyloidosis: ANDROMEDA final survival analysis

Efstathios Kastritis, Giovanni Palladini, Monique C. Minnema, Ashutosh D. Wechalekar et autres

ABSTRACT: In the primary analysis of ANDROMEDA, addition of subcutaneous daratumumab to VCd (bortezomib, cyclophosphamide, and dexamethasone; D-VCd) significantly improved hematologic complete response (CR) rate vs VCd, establishing D-VCd as the only approved therapy for light-chain (AL) amyloidosis. We present results from …

gr, it, nl, gb, us, au, cn, de, il, jp, kr, es, tr, Afrique du Sud, br, fr, ca, pl (code pays fourni par la source)

2 citations Blood
Accès ouvert 2026 article OpenAlex

Association of genetic ancestry with outcomes and toxicity of idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma

Christen Dillard, Hans Lee, Nilesh Kalariya, Naveen G Subramanian et autres

Novel T-cell directed therapies, including chimeric antigen receptor (CAR)-T cells and bispecific antibodies, have transformed treatment for relapsed/refractory multiple myeloma (RRMM). Although myeloma remains largely incurable, BCMA-directed CAR-T therapy has demonstrated unprecedented efficacy with overall response rates (ORR) of 73–100% and complete …

us (code pays fourni par la source)

1 citation Blood Cancer Journal
Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.